Correlation Between Day One and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Day One and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Fate Therapeutics, you can compare the effects of market volatilities on Day One and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Fate Therapeutics.
Diversification Opportunities for Day One and Fate Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Day and Fate is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Day One i.e., Day One and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Day One and Fate Therapeutics
Given the investment horizon of 90 days Day One is expected to generate 2.28 times less return on investment than Fate Therapeutics. But when comparing it to its historical volatility, Day One Biopharmaceuticals is 1.67 times less risky than Fate Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Fate Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 251.00 in Fate Therapeutics on September 1, 2024 and sell it today you would earn a total of 66.00 from holding Fate Therapeutics or generate 26.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Fate Therapeutics
Performance |
| Timeline |
| Day One Biopharmaceu |
| Fate Therapeutics |
Day One and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Fate Therapeutics
The main advantage of trading using opposite Day One and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Day One vs. Tff Pharmaceuticals | Day One vs. Eliem Therapeutics | Day One vs. Inhibrx | Day One vs. Enliven Therapeutics |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |